Lv4
584 积分 2024-07-27 加入
miR-548c-3p targets TRIM22 to attenuate the Peg–IFN–α therapeutic efficacy in HBeAg-positive patients with chronic hepatitis B
2天前
已完结
Identification of potential plasma markers for hepatitis B virus‐related chronic hepatitis and liver fibrosis/cirrhosis
2天前
已完结
Interferon-induced polarization of M1 macrophages mediates antiviral activity against the hepatitis B virus via the hepcidin-ferroportin axis
3天前
已完结
Long‐term antiviral therapy is associated with changes in the profile of transcriptionally active HBV integration in the livers of patients with CHB
4天前
已完结
Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral Therapy
11天前
已完结
B-Cell Activation Gene Signature in Blood and Liver of Hepatitis B e Antigen–Positive Patients With Immune Active Chronic Hepatitis B
11天前
已完结
Differential Regulation of Host Genes Including Hepatic Fatty Acid Synthase in HBV-Transgenic Mice
20天前
已完结
Modulation of Fatty Acid Synthase Enzyme Activity and Expression during Hepatitis C Virus Replication
20天前
已完结
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019
24天前
已完结
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
24天前
已完结
皖公网安备34019202002308
